project id: TCGA-PAAD; case submitter id: TCGA-2J-AAB6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.0; age at index: 75; days to birth: -27600; days to death: 293; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1937; year of death: 2012; age at diagnosis: 27600; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C25.1; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of pancreas; synchronous malignancy: No; tissue or organ of origin: Body of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: No; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 707; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-2J-AAB6-01A-11; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 0.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;